Silymarin attenuates the renal ischemia/reperfusion injury-induced morphological changes in the rat kidney
- PMID: 18408933
- DOI: 10.1007/s00345-008-0256-1
Silymarin attenuates the renal ischemia/reperfusion injury-induced morphological changes in the rat kidney
Abstract
Objectives: Renal ischemia/reperfusion (I/R) injury is associated with increased mortality and morbidity rates due to acute renal failure (ARF). Oxidative stress induced with renal I/R injury directly affects glomerular and tubular epithelium through reactive oxygen species. Several studies have been directed to the treatment of renal I/R injury. The aim of this study was to test the attenuation with silymarin (SM) treatment of renal I/R injury-induced morphological changes in the rat kidney.
Methods: A total of 32 adult male Sprague-Dawley rats were evaluated in four groups. Group I (sham), Group II (renal I/R), Group III (renal I/R injury + SM 50 mg per kg) and Group IV (renal I/R injury + SM 100 mg per kg) were designed to evaluate the dose-dependent effects of SM on the morphological changes of renal I/R injury. Renal I/R injury were induced with left renal pedicle occlusion for 45 min followed with reperfusion for 6 h under anesthesia. After induction of I/R injury, left nephrectomies were performed for histopathological examinations.
Results: After renal I/R injury, significant tubular dilatation, tubular vacuolization, pelvic inflammation, interstitial inflammation, perirenal adipose infiltration, tubular necrosis and glomerular necrosis (cortical necrosis) were observed. However, even with low dose SM in Group III (50 mg per kg SM), histopathological changes due to I/R injury were prevented.
Conclusions: The results of this study have demonstrated that SM significantly prevents renal I/R injury-induced renal tubular changes in the rat. SM in 50 mg/kg was observed to be sufficient to significantly prevent renal tubular necrosis. Further, to our literature knowledge, this is the first specific study to demonstrate the preventive effect of SM on renal I/R injury.
Similar articles
-
Protective role of silymarin in a mouse model of renal Ischemia-Reperfusion injury.Diagn Pathol. 2015 Oct 31;10:198. doi: 10.1186/s13000-015-0436-4. Diagn Pathol. 2015. Retraction in: Diagn Pathol. 2018 Sep 12;13(1):71. doi: 10.1186/s13000-018-0746-4. PMID: 26521234 Free PMC article. Retracted.
-
Effect of dexmedetomidine on ischemia-reperfusion injury in rat kidney: a histopathologic study.Ren Fail. 2009;31(1):70-4. doi: 10.1080/08860220802546487. Ren Fail. 2009. PMID: 19142813
-
The Role of Oxidative Stress, Renal Inflammation, and Apoptosis in Post Ischemic Reperfusion Injury of Kidney Tissue: the Protective Effect of Dose-Dependent Boric Acid Administration.Biol Trace Elem Res. 2020 May;195(1):150-158. doi: 10.1007/s12011-019-01824-1. Epub 2019 Aug 1. Biol Trace Elem Res. 2020. PMID: 31372827
-
Protective effect of oxymatrine against renal ischemia/reperfusion injury in rats.Bratisl Lek Listy. 2017;118(4):217-222. doi: 10.4149/BLL_2017_043. Bratisl Lek Listy. 2017. PMID: 28471232
-
The effect of silymarin on mesenteric ischemia-reperfusion injury.Med Princ Pract. 2014;23(2):140-4. doi: 10.1159/000356860. Epub 2013 Dec 18. Med Princ Pract. 2014. PMID: 24356575 Free PMC article.
Cited by
-
Antioxidant Supplementation in Renal Replacement Therapy Patients: Is There Evidence?Oxid Med Cell Longev. 2019 Jan 15;2019:9109473. doi: 10.1155/2019/9109473. eCollection 2019. Oxid Med Cell Longev. 2019. PMID: 30774749 Free PMC article. Review.
-
Conivaptan and Boric Acid Treatments in Acute Kidney Injury: Is This Combination Effective and Safe?Biol Trace Elem Res. 2022 Aug;200(8):3723-3737. doi: 10.1007/s12011-021-02977-8. Epub 2021 Oct 21. Biol Trace Elem Res. 2022. PMID: 34676519
-
Ameliorative Effect of Silymarin on Scopolamine-induced Dementia in Rats.Open Access Maced J Med Sci. 2018 Jul 17;6(7):1215-1224. doi: 10.3889/oamjms.2018.257. eCollection 2018 Jul 20. Open Access Maced J Med Sci. 2018. PMID: 30087724 Free PMC article.
-
Silymarin mitigates bile duct obstruction-induced cholemic nephropathy.Naunyn Schmiedebergs Arch Pharmacol. 2021 Jun;394(6):1301-1314. doi: 10.1007/s00210-020-02040-8. Epub 2021 Feb 4. Naunyn Schmiedebergs Arch Pharmacol. 2021. PMID: 33538845
-
The flavonoid 6-hydroxyflavone prevention of cisplatin-induced nephrotoxicity.Histol Histopathol. 2020 Oct;35(10):1197-1209. doi: 10.14670/HH-18-251. Epub 2020 Sep 10. Histol Histopathol. 2020. PMID: 32909617
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources